Opiant Pharmaceuticals, Inc. (OPNT): Price and Financial Metrics
OPNT Price/Volume Stats
| Current price | $20.65 | 52-week high | $29.25 |
| Prev. close | $20.77 | 52-week low | $7.34 |
| Day low | $20.50 | Volume | 562,700 |
| Day high | $21.00 | Avg. volume | 77,920 |
| 50-day MA | $20.48 | Dividend yield | N/A |
| 200-day MA | $14.66 | Market Cap | 106.64M |
OPNT Stock Price Chart Interactive Chart >
Opiant Pharmaceuticals, Inc. (OPNT) Company Bio
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops opioid antagonist treatments for addictions and related disorders. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa, an eating disorder; and heroin vaccine. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is based in Santa Monica, California. Opiant Pharmaceuticals, Inc. operates as a subsidiary of Pelikin Group.
OPNT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OPNT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 70.10% |
| 5-year | 128.43% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -39.70% |
| 2021 | 318.80% |
| 2020 | -44.24% |